(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5,5,5-trifluoropentanoic acid, 98.0%, 5g

Methyl 5-fluoro-2-nitrobenzoate, 98.0%, 500g

2-Ethylnicotinic acid, 95.0%, 5g

1-Bromo-4-(1-trifluoromethyl-cyclopropyl)-benzene, 97.0%, 1g

(S)-1-(2-chloro-6-fluorophenyl)propan-1-amine hcl, 95%, 250mg

1,3,4,6-TETRA-O-ACETYL-2-DEOXY-2-(2,2,2-TRICHLOROETHOXYCARBONYLAMINO)-BETA-D-GLUCOPYRANOSE, 95%, 1g

(2R,3S)-1-BENZHYDRYL-2-METHYLAZETIDIN-3-OL, 95.0%, 100mg

Colonne capillaire GC ROTI®Cap-5, 10 m, 0,53 mm, 1,00 µm, 1 pièce(s)

Orientin>98.0%(HPLC)100mg

1,5-Dimethyl-1H-indazole-6-boronic acid, 95.0%, 5g

Lead(II) Iodide (99.99%, trace metals basis) [for Perovskite precursor]>98.0%(T)1kg

2-(4-Bromophenyl)thiazole-4-carbaldehyde, 95.0%, 250mg

2-(Pyridin-3-yl)acetamide, 95.0%, 5g